Trials / Conditions / Recurrent Primary Peritoneal Carcinosarcoma
Recurrent Primary Peritoneal Carcinosarcoma
3 registered clinical trials studyying Recurrent Primary Peritoneal Carcinosarcoma — 2 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Withdrawn | Testing the Addition of ASTX660 (Tolinapant) to the Usual Chemotherapy Treatment (Paclitaxel With or Without B NCT06393751 | National Cancer Institute (NCI) | Phase 1 / Phase 2 |
| Recruiting | MUC1-Activated T Cells for the Treatment of Relapsed and Resistant Ovarian Cancer NCT06483048 | Mayo Clinic | Phase 1 |
| Recruiting | Vaccine Therapy Plus Pembrolizumab in Treating Advanced Ovarian, Fallopian Tube, or Primary Peritoneal Cavity NCT05920798 | Mayo Clinic | Phase 1 / Phase 2 |